Cognitive Decline Following Deep Brain Stimulation
Medical University of South Carolina · NCT05822388
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- April 1, 2023
- Record last updated
- May 29, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This research study aims to identify MRI-based brain biomarkers that predict an individual's response to Deep Brain Stimulation (DBS). In particular, this study will focus on changes in cognition associated with DBS. A total of 55 participants with Parkinson's Disease planning to undergo DBS will be recruited from MUSCs Clinical DBS Program. Participants will undergo four visits, including a 1-hour screening visit, a 1.5-hour pre-DBS MRI scanning visit, and a 3.5-hour post-DBS cognitive assessment visit. In addition control participants without Parkinson's Disease will be recruited to undergo MRI scanning and cognitive assessments.
Being studied: Deep Brain Stimulation Surgical Procedures as Part of Routine Clinical Care
Conditions: Parkinson Disease; Movement Disorders
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
PD Participants
Inclusion Criteria
- Subjects above 18 years of age
- Subjects who will undergo DBS surgery as part of their clinical care for PD
Exclusion Criteria
- Uncorrected visual or hearing impairments, as indicated by self-report
- Individuals who are pregnant or expect to become pregnant during the course of the study
- Individuals with claustrophobia, or the inability to lie supine position in the MRI scanner
- COPD with oxygen dependence
- Non-MRI compatible metal implants (surgical clips or staples, cardiac pacemakers etc.)
Non-PD Control Participants
Inclusion Criteria
- Subjects above 18 years of age
- Age matched to participants in PD group
Exclusion Criteria
- Diagnosis of Parkinsons Disease or other movement disorder
- Untreated neuropsychiatric disorders
- Uncorrected visual or hearing impairments, as indicated by self-report
- Individuals who are pregnant or expect to become pregnant during the course of the study
- Individuals with claustrophobia, or the inability to lie supine position in the MRI scanner
- COPD with oxygen dependence
- Non-MRI compatible metal implants (surgical clips or staples, cardiac pacemakers etc.)
Recruiting US locations
Medical University of South Carolina
Charleston, SC 29425
Site contact: Daniel H Lench, PhD · 843-792-9115 · lenchd@musc.edu
Study contacts (from the official record)
- Daniel H Lench, PhD · 843-792-9115 · lenchd@musc.edu
- Gonzalo J Revuelta, DO · 843-792-7262 · revuelta@musc.edu
Similar studies in South Carolina
All neurology studies in South Carolina →- RecruitingHealthy volunteers
A Study to Evaluate the SENSE Device's Ability to Detect TBI
Sense Diagnostics, LLC
- Location
- Charleston, SC + 5 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Greenville, SC + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Zenas BioPharma (USA), LLC
- Location
- Greenville, SC + 24 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingPhase 3
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Zenas BioPharma (USA), LLC
- Location
- Greenville, SC + 18 other US sites
- Eligibility basics
- Ages 18–60